Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000018

EVP, Strategy & Corporate Dev sold 1,183 shares at $86.91 ($102,820)

  • EVP, Strategy & Corporate Dev acquired 3,048 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dolan Matthew Vincent · EVP, Strategy & Corporate Dev

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-28 Grant or award : show line 1 in the form +3,048 43,227 D
2025-01-29 Sale : show line 2 in the form −1,183 $86.91 $102,820 42,044 D
Open-market sales · 1,183 sh · avg $86.91 · $102,820
Loading xslF345X05/wk-form4_1738280660.xml…